Pyxis Oncology, Inc. (24)
Browse by Contract Category
Contracts
-
Letter Agreement by and between Pyxis Oncology, Inc. and Pfizer Inc., dated October 14, 2022
(Filed With SEC on November 1, 2022)
-
Amended and Restated License Agreement by and between Pyxis Oncology, Inc. and Pfizer Inc., dated October 6, 2022
(Filed With SEC on November 1, 2022)
-
Form of Indemnification Agreement
(Filed With SEC on October 4, 2021)
-
Employment Agreement between Pyxis Oncology, Inc. and Ronald Herbst, Ph.D
(Filed With SEC on October 4, 2021)
-
Pyxis Oncology, Inc. Employee Stock Purchase Plan
(Filed With SEC on October 4, 2021)
-
Lease by and between B9 LS Harrison & Washington LLC and Pyxis Oncology, Inc., dated September 29, 2021
(Filed With SEC on October 1, 2021)
-
License Agreement, dated March 28, 2022 between the registrant and Biosion USA, Inc
(Filed With SEC on May 13, 2022)
-
Description of registrants securities
(Filed With SEC on March 29, 2022)
-
Employment Agreement between Pyxis Oncology, Inc. and Jay Feingold, M.D
(Filed With SEC on October 4, 2021)
-
Employment Agreement between Pyxis Oncology, Inc. and Pamela Connealy
(Filed With SEC on October 4, 2021)
-
Pyxis Oncology, Inc. 2021 Equity Incentive Plan
(Filed With SEC on October 4, 2021)
-
Employment Agreement between Pyxis Oncology, Inc. and Lara Sullivan, M.D
(Filed With SEC on October 4, 2021)
-
Form of Common Stock Certificate
(Filed With SEC on October 4, 2021)
-
Form of Underwriting Agreement
(Filed With SEC on October 4, 2021)
-
Collaboration Agreement by and among Pyxis Oncology, Inc., Alloy Therapeutics, Inc. and Voxall Therapeutics, LLC., dated March 30, 2021
(Filed With SEC on October 1, 2021)
-
Amendment to Opt-In, Investment and Additional Consideration Agreement between Pyxis Oncology, Inc. and LegoChem Biosciences, Inc., dated August 2, 2021
(Filed With SEC on October 1, 2021)
-
Pyxis Oncology, Inc. 2019 Equity Incentive Plan and related form agreements
(Filed With SEC on October 1, 2021)
-
Amended and Restated Investor Rights Agreement, dated March 5, 2021
(Filed With SEC on October 1, 2021)
-
Amendment No. 1 to License Agreement by and between Pyxis Oncology, Inc. and Pfizer Inc
(Filed With SEC on September 17, 2021)
-
Opt-In, Investment and Additional Consideration Agreement between Pyxis Oncology, Inc. and LegoChem Biosciences, Inc
(Filed With SEC on September 17, 2021)
-
First Amendment to License Agreement between Pyxis Oncology, Inc. and LegoChem Biosciences Inc
(Filed With SEC on September 17, 2021)
-
Licensed Agreement between Pyxis Oncology, Inc. and LegoChem Biosciences Inc
(Filed With SEC on September 17, 2021)
-
Exclusive License Agreement between the University of Chicago and Pyxis Oncology for Cancer Immunotherapy Technology
(Filed With SEC on September 17, 2021)
-
License Agreement by and between Pyxis Oncology, Inc. and Pfizer Inc
(Filed With SEC on September 17, 2021)